Medicare Enrolled
Dr. Rory Breidbart, MD
Endocrinology · New Hyde Park, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Breidbart from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Breidbart?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Breidbart
Dr. Rory Breidbart is an endocrinology specialist in New Hyde Park, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Breidbart performed 12,624 Medicare services across 3,533 unique beneficiaries.
Between the years covered by Open Payments, Dr. Breidbart received a total of $120,761 from 52 pharmaceutical and/or device companies across 1030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Breidbart is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 6% volume in NY
$120,761 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,624
Medicare services
Top 6% in NY for endocrinology
3,533
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~631 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,880 | $18 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,365 | $8 | $22 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,010 | $108 | $234 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
845 | $79 | $188 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
580 | $74 | $251 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
248 | $47 | $117 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
200 | $32 | $125 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
159 | $102 | $215 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
118 | $12 | $45 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
60 | $80 | $278 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
46 | $143 | $625 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
33 | $122 | $327 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
23 | $12 | $88 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $53 | $75 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 18 | $20 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $36 | $44 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$120,761
Total received (2018-2024)
Avg $17,252/year across 7 years
Top 6% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
52
Companies
1,030
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$105,150 (87.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,236 (11.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,375 (2.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,834
2023
$9,806
2022
$36,674
2021
$3,899
2020
$6,932
2019
$17,404
2018
$44,212
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Xeris Pharmaceuticals, Inc.
$334
Amgen Inc.
$228
Lilly USA, LLC
$210
Amneal Pharmaceuticals LLC
$175
ABBVIE INC.
$171
SANOFI-AVENTIS U.S. LLC
$124
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$101
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Abbott Laboratories
$80
Radius Health, Inc.
$77
Avvisto Therapeutics, LLC
$62
Dexcom, Inc.
$36
Alexion Pharmaceuticals, Inc.
$34
Novartis Pharmaceuticals Corporation
$29
Tandem Diabetes Care, Inc.
$26
BETA BIONICS, INC.
$23
Esperion Therapeutics, Inc.
$17
Mannkind Corporation
$16
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$42,123
SANOFI-AVENTIS U.S. LLC
$31,531
Merck Sharp & Dohme Corporation
$16,955
Boehringer Ingelheim Pharmaceuticals, Inc.
$16,644
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$3,133
Amgen Inc.
$1,150
AstraZeneca Pharmaceuticals LP
$1,126
Xeris Pharmaceuticals, Inc.
$884
Radius Health, Inc.
$762
Amneal Pharmaceuticals LLC
$687
Novo Nordisk Inc
$633
Abbott Laboratories
$568
Amarin Pharma Inc.
$519
Dexcom, Inc.
$257
AbbVie, Inc.
$255
LifeScan, Inc.
$250
MannKind Corporation
$231
Janssen Pharmaceuticals, Inc
$224
ABBVIE INC.
$213
Becton, Dickinson and Company
$199
AbbVie Inc.
$175
Shire North American Group Inc
$139
PFIZER INC.
$136
Intuity Medical Inc
$135
Novartis Pharmaceuticals Corporation
$129
IBSA Pharma Inc.
$128
DEXCOM, INC.
$128
Insulet Corporation
$114
Gemini Laboratories, LLC
$110
Corcept Therapeutics
$109
Mannkind Corporation
$99
LIFESCAN, INC.
$90
Esperion Therapeutics, Inc.
$88
Alexion Pharmaceuticals, Inc.
$86
Tandem Diabetes Care, Inc.
$84
Medtronic, Inc.
$83
Embecta Corp.
$83
Horizon Therapeutics plc
$69
Medtronic MiniMed, Inc.
$67
Avvisto Therapeutics, LLC
$62
Ultragenyx Pharmaceutical Inc.
$51
Azurity Pharmaceuticals, Inc.
$33
Amryt Pharma Holdings Ltd
$31
Strongbridge US INC.
$28
VistaPharm, Inc.
$25
BETA BIONICS, INC.
$23
Senseonics, Incorporated
$21
Echosens North America, Inc.
$20
CeQur Corporation
$18
Alfasigma USA, Inc.
$17
Zealand Pharma US, Inc.
$16
Valeritas, Inc.
$16
Top 3 companies account for 75.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APRISO · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD Nano 2nd Gen Pen Needle · BD ULTRA-FINE · BD Ultra-Fine · CRYSViTA · CYCLOSET · CeQur Simplicity · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FibroScan · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · INVOKANA · JANUVIA · JARDIANCE · Korlym · LEQVIO · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · ONETOUCH VERIO FLEX · ONETOUCH VERIO REFLECT · OT Verio Reflect "One Touch Meter and Strips" · OT Verio Starter Kit · Omnipod · One Touch Reveal Mobile App · OneTouch · OneTouch Verio Reflect · Ozempic · PAXLOVID · Pogo Automatic Blood Glucose Monitoring System · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNJARDY · SYNTHROID · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Victoza · XARELTO · XIFAXAN · XIFAXANIBSD · Xultophy 100/3.6 · ZEGALOGUE · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for endocrinology in NY.
Geographic Context
Endocrinologists within 10 mi
629
Per 100K population
45.3
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Breidbart is a clinical cardiology specialist, with above-average Medicare volume (top 6% in NY), with speaking/promotional industry engagement in the top 6% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Breidbart experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Breidbart performed 5,880 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Breidbart receive payments from pharmaceutical companies?
Yes. Dr. Breidbart received a total of $120,761 from 52 companies across 1,030 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Breidbart's costs compare to other endocrinologists in New Hyde Park?
Dr. Breidbart's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Breidbart) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in New Hyde Park
Browse endocrinologists in New Hyde Park ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology